The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD

2 years ago 68
ARTICLE AD BOX
The regulatory agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder.
Read Entire Article